| 期刊論文| 1. | 張毓雯、劉士任(20171200)。漫談人類乳突病毒疫苗的現況。感染控制雜誌，27(6)，275-280。 延伸查詢 | | 2. | 鄭舒倖(20180600)。人類乳突病毒疫苗：不只女孩有需要。感染控制雜誌，28(3)，112-118。 延伸查詢 | | 3. | Chao, A.、Jao, M. S.、Huang, C. C.、Huang, H. J.、Cheng, H. H.、Yang, J. E.、Lai, C. H.(2011)。Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese women。International Journal Of Cancer，128(3)，653-659。  | | 4. | Chen, H. C.、Schiffman, M.、Lin, C. Y.、Pan, M. H.、You, S. L.、Chuang, L. C.、Chen, C. J.(2011)。Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer。Journal of The National Cancer Institute，103(18)，1387-1396。 | | 5. | Cooper, S. C.、Davies, C.、McBride, K.、Blades, J.、Stoney, T.、Marshall, H.、Skinner, S. R.(2016)。Development of a human papillomavirus vaccination intervention for Australian adolescents。Health Education Journal，75(5)，610-620。 | | 6. | Giuliano, A. R.、Joura, E. A.、Garland, S. M.、Huh, W. K.、Iversen, O. E.、Kjaer, S. K.、Luxembourg, A.(2019)。Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: Comparison with historic placebo population。Gynecologic Oncology，154(1)，110-117。 | | 7. | Lai, C. Y.、Wu, W. W.、Tsai, S. Y.、Cheng, S. F.、Lin, K. C.、Liang, S. Y.(2015)。The Effectiveness of a Facebook-Assisted Teaching Method on Knowledge and Attitudes about Cervical Cancer Prevention and HPV Vaccination Intention among Female Adolescent Students in Taiwan。Health Education & Behavior，42(3)，352-360。 | | 8. | Mauro, A. B.、Fernandes, E. G.、Miyaji, K. T.、Arantes, B. A.、Valente, M. G.、Sato, H. K.、Sartori, A. M. C.(2019)。Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016)。Revista do Instituto de Medicina Tropical de São Paulo，61。 | | 9. | Sampson, J. N.、Hildesheim, A.、Herrero, R.、Gonzalez, P.、Kreimer, A. R.、Gail, M. H.(2018)。Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine。Contemporary Clinical Trials，68，35-44。 | | 10. | Yaju, Y.、Tsubaki, H.(2019)。Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events。Japan Journal of Nursing Science，16(4)，433-449。 | | 11. | Zhu, F. C.、Hu, S. Y.、Hong, Y.、Hu, Y. M.、Zhang, X.、Zhang, Y. J.、Struyf, F.(2019)。Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial。Cancer Medicine，8(14)，6195-6211。 | 其他| 1. | 蔣宜婷(20180510)。台灣首宗訴訟案揭黑布：HPV疫苗全面公費接種的陰影，https://www.twreporter.org/a/hpvvaccine-adverse-effects。 延伸查詢 | | 2. | 衛生福利部(20161024)。HPV9價/2價疫苗之迷思-科學數據告訴你，https://www.mohw.gov.tw/cp-16-44844-1.html。 延伸查詢 | | 3. | 衛生福利部國民健康署(20181212)。HPV專欄，https://www.hpa.gov.tw/Pages/List.aspx?nodeid=212。 延伸查詢 | | 4. | 衛生福利部國民健康署(20180518)。學生健康行為調查，https://www.hpa.gov.tw/Pages/List.aspx?nodeid=113。 延伸查詢 | | 5. | World Health Organization(2016)。HPV vaccine background document，https://www.who.int/immunization/sage/meetings/2016/october/1_HPV_vaccine_background_document_27Sept2016.pdf?ua=1。 | | 6. | World Health Organization(2019)。Data, statistics and graphics，https://www.who.int/immunization/monitoring_surveillance/data/en/。 | |